The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...
Zacks Investment Research on MSN12h
DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 ApprovalDexCom DXCM is facing regulatory scrutiny following a warning letter recently posted by the FDA. This could affect the ...
Dexcom made a significant design change to a component used in its sensors and did not adequately validate the change, ...
The U.S. FDA’s March 4, 2025, warning letter to Dexcom Inc. is a well-detailed but heavily redacted document explaining the agency’s misgivings about procedures such as monitoring of acetaminophen ...
Over the past six months, DexCom has been a great trade. While the S&P 500 was flat, the stock price has climbed by 8% to $74.17 per share. This run-up might have investors contemplating their ...
A company spokesperson said Dexcom plans to resolve the agency's concerns but stated no design changes were made to its ...
Just like smartphone cameras, these sensors have a finite resolution. The higher the resolution, the finer details the sensor can discern about your finger, increasing the level of security.
Biosensors are devices used to detect the presence or concentration of a biological analyte, such as a biomolecule, a biological structure or a microorganism. Biosensors consist of three parts: a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback